#cetuximab — Friday, October 16, 2026 (1 items)
| 1 | ℹ |
IPO5 contributes to cetuximab resistance in colorectal cancer by modulating Ras signaling.
(linkinghub.elsevier.com)
|
iScience 2026-10-16 | #amr #cancer #cetuximab #signaling #apoptosis |